Lantern Pharma Inc
(LTRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 1,232 | N/A | N/A | N/A |
| TOTAL | $1,233 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 9 | N/A | N/A | N/A |
| Other Non-Current Assets | 191 | 0 | 0 | 0 |
| TOTAL | $200 | $N/A | $N/A | $N/A |
| Total Assets | $1,433 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 489 | 0 | 0 | 0 |
| TOTAL | $489 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $489 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -6,752 | N/A | N/A | N/A |
| TOTAL | $943 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $1,433 | $0 | $0 | $0 |